Core Laboratories N.V. (CLB) Stock Forecast & Price Target

Core Laboratories N.V. (CLB) has an ST Score of 48.3 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Analysts rate CLB a Hold, with a price target of $21.00 (+100.2% vs the current price). Our ST Score grades it C+ (48.3/100). The ST Score is a data-driven signal, not a recommendation.

Valuation C+, Profitability B+, Financial Strength C+, Momentum D-, Growth C-, Forecast A, Sentiment F.

Core Laboratories N.V. (CLB) earns a valuation grade of C+, measured against Oil & Gas Equipment & Services peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Core Laboratories N.V. (CLB) earns a growth grade of C-, measured against Oil & Gas Equipment & Services peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Core Laboratories N.V. (CLB) earns a profitability grade of B+, measured against Oil & Gas Equipment & Services peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Core Laboratories N.V. (CLB) earns a financial strength grade of C+, measured against Oil & Gas Equipment & Services peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for Core Laboratories N.V. (CLB) is $21.00 from 37 analysts, which is +100.2% versus the recent price of $10.49.

Core Laboratories N.V. (CLB) has a Piotroski F-Score of 8 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.